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Abstract
Background: There have been many recent developments of in vitro cigarette smoke systems closely replicating in
vivo exposures. The Borgwaldt RM20S smoking machine (RM20S) enables the serial dilution and delivery of
cigarette smoke to exposure chambers for in vitro analyses. In this study we have demonstrated reliability and
robustness testing of the RM20S in delivering smoke to in vitro cultures using an in-house designed whole smoke
exposure chamber.
Results: The syringe precision and accuracy of smoke dose generated by the RM20S was assessed using a
methane gas standard and resulted in a repeatability error of ≤9%. Differential electrical mobility particle
spectrometry (DMS) measured smoke particles generated from reference 3R4F cigarettes at points along the
RM20S. 53% ± 5.9% of particles by mass reached the chamber, the remainder deposited in the syringe or
connecting tubing and ~16% deposited in the chamber. Spectrofluorometric quantification of particle deposition
within chambers indicated a positive correlation between smoke concentration and particle deposition. In vitro air-
liquid interface (ALI) cultures (H292 lung epithelial cells), exposed to whole smoke (1:60 dilution (smoke:air,
equivalent to ~5 μg/cm
2)) demonstrated uniform smoke delivery within the chamber.
Conclusions: These results suggest this smoke exposure system is a reliable and repeatable method of generating
and exposing ALI in vitro cultures to cigarette smoke. This system will enable the evaluation of future tobacco
products and individual components of cigarette smoke and may be used as an alternative in vitro tool for
evaluating other aerosols and gaseous mixtures such as air pollutants, inhaled pharmaceuticals and cosmetics.
Background
Molecular mechanisms and pathways elucidating cigar-
ette smoking disease processes are still not well under-
stood. Abundant epidemiological studies and research
have linked smoking to a number of diseases including
lung cancer, chronic obstructive pulmonary disease and
cardiovascular disease; identified inflammatory and oxi-
dant stress mechanisms having a pivotal role in all of
these processes [1]. Physiologically-relevant in vitro
model systems, in which human lung cells and tissues
can be exposed to appropriate doses of cigarette smoke
may provide useful tools to interpret these processes
and identify other mechanisms. There are numerous
studies reporting the development of such in vitro
models utilising a variety of cell types and systems [2-8].
However, just as the selection and cultivation of these
selected cells and systems are important, so too is the
development, generation and delivery of cigarette smoke
to these in vitro assays.
Traditionally, toxicological evaluation of cigarette
smoke has focussed on the particulate fraction of
smoke. The particulate matter (PM) from cigarette
smoke is collected on a Cambridge filter pad [9] and
eluted with an organic solvent such as methanol or
dimethyl-sulphoxide to generate a solution [10,11]
which can be easily added to traditional submerged in
vitro cultures. This fraction of cigarette smoke only con-
tains the particulate element, which constitutes approxi-
mately 5-10% of cigarette smoke by weight. The
remaining 90-95% constitutes the gas/vapour phase of
smoke and is not captured on the Cambridge filter pad
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© 2011 Adamson et al[12]. Water-soluble cigarette smoke components from
both particulate and vapour phases can be captured by
bubbling cigarette smoke through biological buffers or
tissue culture media. This resulting ‘aqueous extract’ can
also be easily assessed in submerged in vitro cultures
[13-15]. However, in order to understand the toxicologi-
cal and biological effect of cigarette smoke, the whole
cigarette smoke, i.e., both particulate and vapour phase,
needs to be analysed.
Recently there has been an increase in the develop-
ment of novel whole smoke exposure systems to gener-
ate and deliver whole cigarette smoke to in vitro cellular
culture systems for toxicological and biological assess-
ment [16]. There are many smoke machines commer-
cially available including systems such as the Borgwaldt
RM20S (RM20S) smoking machine [7,17-19], the Bur-
ghart Mimic Smoker-01
® [20] and the Vitrocell
® VC
10
® Smoking Robot [21]. There are also several cell
exposure chambers/systems described in the literature
including CULTEX
® modules [22] the rocking platform
system [23] and British American Tobacco’s( B A T )
exposure chamber (Figure 1) [7,17]. These exposure sys-
tems are of greater physiological relevance compared to
traditional submerged exposure methods as they support
cell cultures cultured at the air-liquid interface (ALI)
and enable the exposure of cells to both phases of
smoke simultaneously, capturing any synergies or inter-
actions between the two. Despite these advances, there
have been few studies to characterise cigarette smoke in
these systems [20].
At BAT we are investigating the use of a number of
these smoking machines, including the RM20S smoking
machine (Figure 2). The RM20S generates, dilutes and
delivers whole smoke to in vitro cultures placed in an
exposure chamber. Serial dilutions are made via multiple
steps of filling and partial emptying of the syringe once
filled with smoke and air. The exposure chamber houses
cell inserts, such as commercially available Transwells
®,
providing a porous support for ALI cultures to be dosed
apically with cigarette smoke and for warmed cell cul-
ture media to be delivered basally. The RM20S is com-
mercially supplied as a four syringe smoking machine
and has been previously assessed for robustness of
smoke delivery [18].
In conjunction with Borgwaldt, we have expanded the
capability of the smoke delivery system with the addi-
tion of another four syringe unit. This addition has
resulted in a new expanded eight syringe system, requir-
ing characterisation which has not been conducted pre-
viously. Adapting the system from four to eight syringes
increases the number of available whole smoke doses
per run and reduces the number of experimental runs
(eliminating the need for back-to-back runs) which
results in a single biological dose response to be carried
out in one experimental run. This adaptation will
enhance the RM20S by increasing flexibility in experi-
mental design, by reducing inter-run variability and by
saving time.
The aim of this study was to characterise and evaluate
the performance of the expanded RM20S eight syringe
smoking machine and to assess cigarette smoke through
the system. Initially all syringes were calibrated for pre-
cision and accuracy. Using a hydrocarbon analyser and
test gas the syringes could be tested to confirm to what
extent, collectively and individually, smoke was being
delivered at its target dilution. The penetration and
deposition of cigarette smoke particulate throughout the
RM20S whole smoke exposure system was investigated
using two dosimetry techniques. The first employed the
use of differential electrical mobility particle spectrome-
try (DMS) to enable in-line and real-time particle dia-
meter and concentration measurement of smoke along
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Figure 1 Exposure chamber (left) patent publication number WO 03/100417 A1 and schematic cross-section (right), [7].
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Page 2 of 11the whole smoke system [24]. It had been previously
reported by Scian et al., (2009) that the Burghart Mimic
Smoker-01
® system has smoke losses of up to 50% pre-
ceding delivery to cells [20]. Data generated from the
DMS would enable us to calculate smoke losses experi-
enced in our exposure system and compare them to this
recent study. The second technique used spectrofluoro-
metric analysis to quantify particulate deposition on
inserts within the exposure chamber during whole
smoke exposures. Particulate is extracted followed by
absorbance measurements which can be converted into
concentrations using a PM standard curve. Finally, to
confirm previous non-cell based methods [17] using cell
cytotoxicity, positional exposure chamber dosimetry was
examined to ensure the same dose of cigarette smoke
was being delivered to each insert within a single cham-
ber. H292 lung epithelial cells were cultured on indivi-
dual inserts within an exposure chamber, exposed to
whole smoke and cytotoxicity assessed using the Neutral
Red Uptake (NRU) assay.
Results from this study have given us further confi-
dence that the current whole smoke exposure system,
using the Borgwaldt RM20S smoking machine and the
BAT exposure chamber, is a reliable, repeatable, robust
and potentially a more physiologically relevant method
of generating and exposing in vitro cellular and tissue
cultures to whole cigarette smoke at the ALI. We pro-
pose to further characterise whole smoke dosimetry
relative to specific smoke constituents and to use this
system for the evaluation of novel cigarette design
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Figure 2 The Borgwaldt RM20S 8 syringe smoking machine. The dilutor syringes work independently, with the capability of delivering an
extensive smoke dilution range (1:2 -1:4,000 [smoke:air, v/v]) and delivering up to eight different doses of whole smoke simultaneously. A -
cigarette smoke generator; Bi - original 4-syringe unit; Bii - additional 4-syringe unit enabling 8 concurrent dilutions in a single run; C - a single
BAT exposure chamber housed in an incubator at 37°C attached to smoke generator and media (up to 9 chambers can be installed in the
incubator shown, one connected to each syringe plus an air control); D - cell culture media maintained at 37°C in an incubator, supplied to
chambers using a pump; E - airflow fan controller.
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Page 3 of 11modifications proposed to reduce toxicants in smoke
and to further investigate individual components of
cigarette smoke.
Results
Syringe validation using hydrocarbon analysis
Initially, before conducting any in vitro whole smoke
exposures with the RM20S, all eight syringes were cali-
brated for precision and accuracy using a methane stan-
dard gas. Using a hydrocarbon analyser and methane
test gas at two dilutions (1:193 and 1:500 (test gas:air,
volume:volume)), the syringes, individually and collec-
tively, were assessed to determine if they were achieving
the target deliveries of 520 ± 20 ppm and 200 ± 15 ppm
methane gas standard respectively.
At a dilution of 1:193 individual syringe precision sug-
gested no bias of average syringe outputs (Figure 3A). All
eight syringes delivered with little variability at the target
level of 520 ± 20 ppm. Repeatability, which is an average
of how individual syringes are performing as a percentage
of the nominal values, was calculated at 2.3%. Collective
syringe performance was assessed using the Repeatability
and Reproducibility (Gage R&R) estimate, which indicates
consistency and stability of syringe performance across the
entire system, and as a percentage of the nominal values
was 3%. All of these R-values were < 10%, which are gen-
erally accepted limits in measurement systems indicating
the equipment is fit for purpose [25].
At a dilution of 1:500, individual syringe precision
indicated a 15% positive bias of average syringe outputs
about the target (200 ± 15 ppm) (Figure 3B). Dunnet’s
test showed that collectively the syringes were signifi-
cantly different from the target. Repeatability, as a per-
centage of the nominal values, was 5% and the Gage
R&R estimate as a percentage of the nominal values was
8.9%. Although bias was significant, it only accounts for
the overall position o ft h ed a t aa n dn o tt h eprecision of
syringe delivery, therefore bias can be significant yet the
R&R estimate be fit for purpose within the same sce-
nario. All of these values were < 10%, and hence
deemed to be fit for purpose despite significant bias.
A two-way ANOVA was conducted to assess the syr-
inge outputs across both dilutions and overall accuracy.
At the dilutions measured there was no significant dif-
ference in the syringes (p = 0.051). Total Gage R&R was
2.9%, reproducibility was 2.2% and repeatability was
1.9% for the entire syringe system at both dilutions
tested. These results show that collectively the syringe
system is fit for purpose.
Smoke transfer efficiency using an electrical mobility
spectrometer
The penetration and deposition of particulate through-
out the RM20S whole smoke exposure system was
investigated using an electrical mobility spectrometer
(DMS). The DMS sampled whole smoke at the exit of
the syringe after the primary dilution (a), pre-entry to
the chamber (b)a n da tt h ee x i tf r o mt h ec h a m b e r( g),
shown in Figure 4. Additionally, a three-way comparison
of different tubing types was conducted; the types tested
were existing polyurethane (the tubing installed in the
RM20S upon manufacture and having a visible build up
of tar), unused polyurethane and unused Viton
®,a
PTFE-like fluoroelastomer (non-stick).
Particle penetration was calculated by both particle
mass and number, by comparing the total smoke parti-
culate at three points. The values were reported relative
to 100% smoke mass equivalent to 5.75 ± 0.31 mg
(assuming unit density), and 100% smoke particle num-
ber equivalent to 1.44 × 10
12 ±0 . 1 0×1 0
12 particles (n
= 3) for 10 puffs from 2 cigarettes (6+4) as measured by
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Figure 3 The precision of eight individual syringes using
hydrocarbon analysis. A methane gas standard was diluted by the
eight Borgwaldt RM20S syringes and precision was calculated as a
function of accuracy of dilution delivery. A - syringe precision at a
dilution of 1:193 (smoke:air, v/v) against a target value of 520 ppm
methane gas standard, n = 15. B - syringe precision at a dilution of
1:500 (smoke:air, v/v) against a target value of 200 ppm methane
gas standard, n = 15, * = outliers.
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tion at the point of generation. This matches the 10 puff
data collection at the other sample points. Data was cor-
rected for the theoretical delivered fraction at each sam-
pling point as calculated based on the dilution settings
and mechanism. Pre-chamber losses were calculated by
the difference in smoke concentration between the point
of smoke generation (100%) and the chamber (b), and
chamber deposition was calculated by the difference in
smoke concentration before (b)a n da f t e r( g)t h e
chamber.
As shown in Figure 5, very similar DMS dosimetry
results were achieved using the different tubing
types, suggesting that the choice of tubing type did
not matter for these three; there was no statistically
significant difference between the three types tested,
p = 0.083, but there was significant difference
between the three sampling points a, b and g for all
three, p = < 0.05. Pre-syringe losses based on particle
mass for existing polyurethane were 14%, with 86%
particle mass being detected at the exit of the syringe
(a). Pre-chamber losses were 47% in total, 33% of
which was lost/deposited within the syringe and con-
necting tubing (the difference between a and b), with
53% average particle penetration to the chamber.
Chamber particle deposition by mass was 16%, but it
must be noted that this was a mixture of fresh and
old smoke.
Table 1 summarises all the data generated from exist-
ing polyurethane only (as there was no significant differ-
ences between the three types tested, and existing
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Figure 5 Assessment of cigarette smoke particle mass
penetration through the RM20S system, using three different
tubing types. An electrical mobility spectrometer sampled smoke
at the exit of the syringe (a), before the chamber (b) and at the exit
from the chamber (g). Results expressed as percentage of average
mainstream smoke (100% = 5.75 ± 0.31 mg) n = 3. Statistically
significant differences were observed between the three sampling
points (a, b, g) for all tubing types tested, p = < 0.05, but no
significant differences were observed between the three tubing
types at each individual sampling point, p = 0.083.
Table 1 Summary of the assessment of total cigarette
smoke particulate sampled at the exit of the syringe (a),
before the chamber (b) and at the exit from the chamber
(g) using an electrical mobility spectrometer; existing
polyurethane was the tubing installed
abg
Particle mass penetration (%) 86
± 3.2
53
± 5.9
37
± 4.9
Particle number penetration (%) 14.7
± 0.5
10.3
± 0.6
8.3
± 0.7
Count Median Diameter (nm) 301.0
± 1.1
293.9
± 5.8
289.1
± 5.8
Volume Median Diameter (nm) 422.9
± 2.8
393.8
± 10.4
360.8
± 8.9
Particle penetration was calculated by both particle mass and number, by
comparing the total smoke particulate to the sample points a, b and g and
reported relative to 100% smoke mass equivalent to 5.75 ± 0.31 mg
(assuming unit density) and 100% smoke particle number equivalent to 1.44 ×
1012 ± 0.10 × 1012 particles (n = 3). Significant differences were observed
between all sampling points for particle mass, number and VMD, and for CMD
between the a and g sampling points (p = < 0.05); there were no significant
differences for CMD between a and b (p = 0.0549), and between b and g
(0.7384).
Figure 4 Schematic cross-section of a single RM20S syringe
and exposure chamber. Smoke was sampled at the exit of the
syringe (a), pre-entry to chamber (b) and at the exit from the
chamber (g) using an electrical mobility spectrometer.
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type). Percentage of particle number penetration was
lower than particle mass penetration and this is likely
due to coagulation; particle mass is conserved but parti-
cle number reduces as particles collide and coalesce
during early transit. However, preferential diffusional
and evaporative losses of smaller particles within the
distribution are also feasible. The reductions in Count
Median Diameter (CMD) were not as pronounced as
the reductions in Volume Median Diameter (VMD) at
the three points tested, and this suggests that larger par-
ticles were depositing preferentially in the tubing and
syringe.
Pairwise comparison using the General Linear Model
showed that there were statistically significant differ-
ences (p = < 0.05) between all three sampling points in
terms of particle number, particle mass and VMD. How-
ever, for CMD there was only a significant difference
between the a and g sampling points; for CMD there
was little difference between a and b (p = 0.0549), and
between b and g (0.7384).
Deposition assessment using fluorometric analysis
Particulates from 3R4F reference cigarettes (10 mg tar)
deposited onto the inserts in the exposure chamber dur-
ing whole smoke exposures were eluted, quantified
using fluorescence spectroscopy and converted to μg/
cm
2 using a PM standard curve. The particulate deposi-
tion data was plotted onto a calibration graph (insert
deposition against corresponding Borgwaldt RM20S
smoke dilution) using GraphPad Prism version 5.02.
Both axes were logged and a linear regression created
(Figure 6).
The linear range of the graph was over 2 orders of
magnitude for smoke dilution (1:5 - 1:400 (smoke:air, v/
v)) with particle mass deliveries of 60.74 - 0.63 μg/cm
2.
The Limit of Quantification (LOQ) and Limit of Detec-
tion (LOD) were calculated to be 0.448 and 0.247 μg/
cm
2 respectively. The R-square value for the linear
regression was 0.916. As expected, the data showed that
there was a positive correlation between smoke concen-
tration and particulate depositing on the inserts.
The calibration graph enabled the interpolation of
either an insert particulate concentration from a desired
smoke dilution or vice versa. The linear regression can
be used to generate the following table (Table 2) dis-
playing the equivalent insert particulate deposition
values (μg/cm
2) for a specific Borgwaldt RM20S smoke
dilution.
Exposure chamber dosimetry
Cell cytotoxicity, using the NRU assay was used to
assess individual insert whole smoke dose within a sin-
gle chamber, to investigate positional exposure chamber
dosimetry. Cell viability was calculated as a percentage
of the air controls (as described in the methods) and
incubator controls were included in every run to use as
a comparator/indicator of cell stress and sterility. Mean
viability across all six inserts was 46 ± 9.8% (p = 0.56, n
= 20). Figure 7 indicates there was no significant differ-
ence between individual inserts exposed to cigarette
smoke in a single exposure chamber, suggesting uniform
smoke distribution in the chamber. The data range how-
ever suggests that the inter-run variability is large within
each individual Transwell
® rather than intra-run
variability.
Discussion
In this study we present a characterised and evaluated
system used to generate, dilute, deliver and expose in
vitro cell cultures to whole smoke at the ALI. The integ-
rity of whole smoke generated and delivered to in vitro
cultures was assessed using a measurement systems ana-
lysis approach. We characterised three key areas within
the exposure system; delivery and accuracy of dilution
syringes, smoke particle penetration and smoke losses
10
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Figure 6 Transwell particulate deposition (μg/cm
2)a td i f f e r e n t
smoke dilutions for a 30 minute whole smoke exposure.
Table 2 Summary of calculated 3R4F particulate deposition
on inserts within the exposure chamber (μg/cm
2)
Smoke dilution
(smoke:air, v/v)
Equivalent 3R4F particulate deposition (μg/cm
2)
1:5 60.74 ± 2.07
1:10 29.47 ± 1.30
1:25 11.33 ± 0.59
1:50 5.50 ± 0.58
1:100 2.67 ± 0.13
1:250 1.03 ± 0.11
1:400 0.63 ± 0.09
Chambers were exposed to various whole smoke dilutions during a 30 minute
exposure to 3R4F reference cigarettes smoked at the ISO regime. Particles
deposited on inserts were measured by fluorescence detection. Deposited
particulate matter was eluted with a solvent and quantified against a standard
curve produced from 3R4F cigarette smoke total particulate matter.
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Page 6 of 11through the system, and positional deposition in the
exposure chamber.
Individual syringe precision and accuracy were mea-
sured using the hydrocarbon analysis method
described. The syringes were tested at two dilutions,
1:500 and 1:193 (a calibration standard dilution), as
this represents the extreme top and mid dilutions
respectively used in the laboratory to generate a biolo-
gical dose response range using robust in vitro primary
and continuous cell cultures [7,17]. We observed more
variation about the higher dilution of 1:500, target
value of 200 ppm methane gas, when compared to the
lower dilution of 1:193, target value of 520 ppm
methane gas; this was primarily because the syringe
sensors were adjusted at the latter dilution. At a dilu-
tion of 1:500 there was a positive bias about the target
of 15%, suggesting at this dilution, collectively the syr-
inges were delivering 15% more gas, and could there-
fore deliver 15% more smoke. This is something which
cannot currently be improved upon, as bias fluctuates
at different dilutions tested, but this can be adjusted
for with further syringe calibration.
Furthermore, earlier evaluations from data taken at
four dilution levels (1:1000, 1:500, 1:250, 1:193) demon-
strated that both repeatability and the Gage R&R esti-
mate improved as the dilution was decreased (smoke
concentration increased) towards the biological dose
response range previously described (data not shown).
This may be due to the reduction in serial dilutions the
syringe has to make as smoke concentration increases,
and therefore eliminating additional stages of potential
error. At a dilution of 1:193 there was no bias of syringe
delivery about the target and the Gage R&R estimate
was 3%. Statistical analysis indicated no significant dif-
ferences in the syringes and Total Gage R&R to be
within acceptable limits (< 10%). These results have
demonstrated that within the biological dose response
range, individual syringe precision and accuracy of
whole smoke dilutions are fit for purpose which sug-
gests confidence in the programmed dilution of smoke
generated by the RM20S. This study is further sup-
ported by a previous RM20S inter-laboratory study by
Kaur et al., (2010) comparing syringe validation using
CH4 measurements; in two different laboratories and
with two different operators there was comparable
reproducibility and precision for commonly used whole
smoke dilutions [18].
For whole smoke exposure systems in general, it is
important to understand smoke losses and smoke
changes between the point of generation and exposure
chamber and smoke deposition within the chamber
itself. Looking only at the existing polyurethane (pre-
ferred tubing), average particle penetration to the cham-
ber was 53% by mass, implying that there are losses
(about 47%) within the syringe or within the tubing
between the syringe and the chamber. This is also con-
sistent with the Burghart Mimic Smoker-01
® system
which reported smoke losses of up to 50% preceding
delivery to cells [20]. Repeat studies indicated smoke
penetration was very consistent in the RM20S, so smoke
delivered to the chamber will be consistent at this dilu-
tion setting of 1:60 (smoke:air, v/v).
Particle penetration by number to each of the sam-
pling points was significantly less than particle mass. It
is the loss of particle number prior to a that is impor-
tant; this is assumed to be caused by significant pre-
dilution coagulation of particles resulting in reduced
particle number (14% reduction in number). The per-
centage particle loss by number and mass between sam-
ple point a and sample point b was relatively consistent;
30% number and 40% by mass lost (relative). Addition-
ally the VMD at sample point b (393.8 nm) was less
than at sample point a (422.9 nm). These imply that
larger particles are preferentially being lost in the syr-
inge/tubing. Therefore it is likely that most of the
observed losses occurred in the syringe during the gen-
eration of serial dilutions of smoke and turbulent air-
flow, and there is evidence for this in the rapid visual
build-up of tar on the glass surface during frequent
usage.
Furthermore we investigated the use of other tubing
types in the RM20S system: existing polyurethane (used
tubing, currently installed in the RM20S and having a
visible build up/conditioning of tar), unused polyur-
ethane and unused Viton
®, a PTFE-like non-stick fluor-
oelastomer. Identical DMS dosimetry studies using
different tubing types, including the Viton
®, suggest that
the choice of tube material did not matter for these
three.
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Figure 7 Exposure chamber dosimetry investigated using NRU;
cytotoxicity in H292 cells exposed to a smoke dilution of 1:60
(smoke:air, v/v) in 12 mm Transwells
® in a single exposure
chamber. Dotted line represents 50% viability (EC50). Mean viability
= 46 ± 9.8%, p = 0.56, n = 20.
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also assessed particulate deposition using high perfor-
mance liquid chromatography. Particulate, generated
from different whole smoke doses from reference 3R4F
cigarettes (10 mg tar), captured on blank inserts were
collected, eluted, and quantified in μg/cm
2 using a PM
standard curve. A reference table was generated from
the data obtained to allow comparisons between parti-
culate deposition and whole smoke dilution. We have
conducted similar studies using other cigarette types
with different tar deliveries (6 mg and 1 mg ISO pack
tar compared with 3R4F 10 mg ISO pack tar). Data
indicated there was a clear difference in particulate
depositing on the inserts from each of the different
cigarette types, with a greater amount of particulate
depositing from the highest delivery 10 mg 3R4F pro-
duct, followed by the 6 mg product which in turn is
greater than the 1 mg product. For example, at a 1:5
smoke dilution (smoke:air, v/v) generated by the
RM20S, particulate delivery was 61.05 ± 2.07, 38.11 ±
2.21 and 3.09 ± 0.21 μg/cm
2 for the 10, 6 and 1 mg
products respectively.
Finally, exposure chamber dosimetry was assessed by
measuring cell viability within a single chamber, and
comparing cell inserts which were exposed to the same
dilution of cigarette smoke. Previous studies on the
Borgwaldt RM20S and exposure chamber using chemi-
cal analysis techniques reported particulate deposition in
the chamber to be uniform [17] however this had never
been tested before using a biological endpoint. Cell via-
bility assessed using the NRU assay was used as a quick
and robust method to test for differences in doses
between cell inserts. As verified by a p-value of 0.56,
there was no significant difference in cell viability at the
dose tested within a single chamber, demonstrating that
smoke/cell monolayer interactions were equal across all
inserts within a chamber (mean viability 46 ± 9.8%).
Materials and methods
Cell culture and whole smoke exposure
Human pulmonary carcinoma cells (NCI-H292) from
the American Type Culture Collection (ATCC; passages
90-94) were cultured in complete RPMI cell culture
medium and incubated at 37°C, 5% CO2.C e l l sw e r e
seeded in 12 mm diameter, 0.4 μmp o r es i z ei n s e r t s
(Transwell
®, Corning, Schiphol-Rijk, The Netherlands) 2
days prior to exposure, at a density of 3 × 10
5 cells/ml.
Cells were exposed to mainstream cigarette smoke at
the air-liquid interface, using the BAT exposure cham-
ber as previously described (Figure 1) [7,17]. In brief, six
inserts were placed in a single exposure chamber and
exposed to cigarette smoke for 30 minutes at a dilution
of 1:60 (smoke:air, v/v); this is approximately the half
maximal effective concentration (EC50) of 3R4F cigarette
whole smoke to induce 50% cytotoxicity in exposed
H292 cells, as determined by previous experiments [17].
Air and incubator controls were also included in each
run. Air control cells were exposed to a continuous flow
of sterile air in an exposure chamber, at 200 cm
3/min
for a 30 minute duration, at the same time as whole
smoke exposed cells. Incubator control cells remained
in submerged condition in cell culture incubators
throughout the exposures.
Cigarette smoke generation
3R4F reference cigarettes (10 mg ISO pack tar) (Uni-
versity of Kentucky, Kentucky, USA) were smoked at a
programmed dilution of 1:60 (smoke:air, v/v) according
to ISO 4387:1991 [10] (35 ml puff over 2 seconds,
once a minute), as previously described [17]. Between
puffs, smoke was allowed to remain in the exposure
chamber and was only expelled passively when the
next puff replaced it. Allowing smoke to age during
the deposition phase of the cycle in this exposure sys-
tem differs from alternative flow-through systems for
smoke exposure reported elsewhere [20-22]. The ratio-
nale in this case was to increase relative deposition
efficiency and improve precision of deposition by
allowing diffusion and sedimentation from still air in a
symmetrical exposure chamber. The 3R4F cigarettes
were conditioned for a minimum of 72 hours prior to
smoking (60 ± 3% relative humidity, 22 ± 1°C) accord-
ing to ISO 3402:1999 [26]. Prior to smoking, three
quality checks were performed on the RM20S as fol-
lows: the air velocity was verified to be 20 ± 3 cm
3/
sec; checks were performed for air leaks (acceptable
range of pressure between 2750 and 3000 Pa); and the
puff volumes were adjusted on each syringe to 35 ±
0.3 ml [18].
Syringe validation using hydrocarbon analysis
To assess syringe accuracy and precision within the
Borgwaldt RM20S, a total hydrocarbon analyzer - 3010P
MINIFID Portable Heated Flame Ionisation Detection
(FID) (Signal Group Ltd, Surrey, UK) was used to mea-
sure syringe output, as recommended by Borgwaldt.
This FID has a stated accuracy of better than ± 0.2
ppm, with linearity better than ± 0.05 ppm for an ana-
lyte range of 0-100,000 ppm hydrocarbon, so was there-
fore well suited for this study as the measured CH4
concentrations ranged between 100-520 ppm [18]. A
10% (± 0.5%) methane/nitrogen (CH4/N2) test gas (Air
Products PLC, Cheshire, UK) was diluted by all 8 syr-
inges simultaneously, in the same way they would dilute
cigarette smoke.
Each syringe output line was attached to a separate,
vacuumed, 1.5 litre gas collection bag. After 9 minutes
of syringe dilution and methane test gas collection (the
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detached and the contents read using the hydrocarbon
analyser. The analyser ignition fuel used was a mixture
of hydrogen and helium gases (40% H2, 60% He) (Air
Products PLC, Cheshire, UK). The analyser calibration
gas was 500 parts per million (ppm) methane/air (Cryo-
Service Ltd, Worcester, UK).
The contents of each bag were recorded as ppm of the
total methane test gas collected, and these were com-
pared to a target ppm value for the dilutions used. Two
dilutions were tested alternately to reduce mechanical
bias, 1:500 and 1:193 (gas:air, v/v); n = 15 was the data
set for each. The dilutions of 1:500 and 1:193 (a calibra-
tion standard dilution) were selected as this represents a
low and mid dose of smoke respectively in the H292
cell line biological dose response range; the typical
range being 1:1000 - 1:20 [17]. Methane target values
for 1:500 and 1:193 were 200 ppm and 520 ppm respec-
tively. Between alternate dilutions, gas collection bags
were vacuumed with a pump and a clearing puff was
initiated on the RM20S to clear all syringes and tubing
of residual gas.
Smoke transfer efficiency using an electrical mobility
spectrometer
To assess the extent of whole smoke loss/deposition
within the tubing of the Borgwaldt RM20S smoking
machine, an electrical mobility spectrometer - Differen-
tial Mobility Spectrometer 500 (DMS) (Cambustion Ltd,
Cambridge, UK) was used. The DMS sampled all the
smoke per puff reaching the sampling port over all 10
puffs used for assessment and recorded the average par-
ticle diameter, number and volume concentration, flow
rate and time period of each sample to calculate the
total number and volume of particles at different regions
along the tubing.
T h es a m es i n g l es y r i n g eo ft h eR M 2 0 Sa n dt h es a m e
exposure chamber were used in combination for all
readings to reduce inter-syringe variability and syringe-
chamber pairing bias. Samples for aerosol analysis were
taken at three points along its length: (a)t h es y r i n g e
exhaust line; (b) pre-exposure chamber and (g)p o s t -
exposure chamber (Figure 4). Readings at these three
key points along the tubing were used to quantify, qua-
lify and calculate smoke losses within the system.
The amount of smoke at the point of generation could
not be measured directly in the RM20S smoking
machine as there was no suitable access point - the ear-
liest accessible point was a, the exhaust port of the first
syringe between four and six seconds after puff initia-
tion. Measurement at the generation point was esti-
mated by smoking the same cigarettes (3R4F) and
measuring using the same DMS electrical mobility spec-
trometer. In this case a smoking cycle simulator (SCS)
(Cambustion Ltd, Cambridge, UK) was used as the
smoking engine at the ISO regime allowing direct sam-
pling over zero to two seconds from puff initiation via a
constant flow sampling system [27]. These primary data
were used to calculate subsequent smoke losses within
the system.
The DMS was set to a secondary dilution of 1:60 to
take a readings, as the smoke from the syringe at this
stage was concentrated, but no secondary dilution for
the b and g readings was required. For g readings the
chamber was filled with 30 ml Dulbecco’sM o d i f i e d
Eagles Medium (DMEM) (Fisher Scientific UK Ltd,
Loughborough, UK) to mimic usual exposure conditions
and to give the correct internal volume and humidity;
media-in and media-out ports were blocked. A tap was
also inserted between the DMS line and the chamber
for the g readings, and was only opened for 8 seconds to
sample aged smoke when the syringe was exhausting
fresh smoke into the chamber; this stopped the DMS
pump continually pulling smoke from the syringe line
through the chamber and causing a vacuum. This is
representative of whole smoke exposures to in vitro cul-
tures in our laboratories using the RM20S.
A three-way comparison of different types of tubing
was conducted on the RM20S to assess their individual
performance and to see if there was a significant reduc-
tion in smoke loss using one type of tubing over
another. The three tubing types compared were: existing
polyurethane (the current used tubing installed in the
RM20S upon manufacture, and having a visible build
up/conditioning of tar), unused polyurethane (Farnell,
Leeds, UK) and unused Viton
® (Altec Products Ltd,
Cornwall, UK), a PTFE-like fluoroelastomer. The tubing
type order and the order in which the position was read
along the tubing was fully randomised and repeated
three times. The length of tubing used for each smoke
run was 3.4 m irrespective of tubing type. For unused
Viton
® and unused polyurethane, new lengths of tubing
were installed for each repeat experiment; when condi-
tioned polyurethane was removed for another type of
tubing, it was retained and later reinstalled for repeat
experiments.
Deposition assessment using fluorometric analysis
Particle deposition within the whole smoke exposure
chamber was determined by exposing inserts without
cells to 3R4F reference cigarette smoke at a range of
dilutions, minimum of n = 4 per dilution. Before smoke
exposure, blank inserts were pre-wetted with deionised
water and placed into the chambers. Whole smoke was
generated and delivered as previously described. Depos-
ited particulate material was extracted from inserts
using 2 ml of high performance liquid chromatography
(HPLC) grade methanol (Hayman Ltd, Essex, UK) with
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utes. This procedure was repeated using a blank/
untreated insert as a control.
Extracts were analysed by HPLC using an Agilent
1100 Series (Agilent, UK). Elution was performed isocra-
tically with a methanol flow rate of 1 ml/minute and a
sample injection volume of between 3-10 μl. Fluores-
cence was detected with an Agilent standard FLD cell
(Agilent, UK) at excitation and emission wavelengths of
286 nm and 350 nm respectively. Particulate concentra-
tions of the insert extracts were calculated from the
standard calibration curves and the blank insert results
subsequently subtracted from the extract values. Chem-
Station Rev.A.10.02 (Agilent, UK) software was used to
undertake instrument control and quantification. Sample
extracts were quantified against an external standard
prepared from 3R4F generated PM [17]. The standard
calibration curve was prepared from PM concentrations
ranging from 0.48 - 38 μg/ml.
Neutral Red Uptake
After whole smoke exposure, cells were transferred to
complete Ultraculture (Lonza Biologics Plc, Tewkesbury,
UK) containing 2 mM glutamine, 50 U/ml penicillin
and 50 μg/ml streptomycin (Invitrogen, Paisley, UK) and
i n c u b a t e da t3 7 ° C ,5 %C O 2 for a 24 hour recovery per-
iod. After incubation, the Neutral Red Uptake (NRU)
assay was performed to assess cell viability in each insert
as previously described, based on the National Institutes
of Health [28].
Briefly, media was removed from each insert and
replaced with 50 μg/ml Neutral Red solution (Sigma-
Aldrich Company Ltd, Dorset, UK) for 3 hours, to allow
for the active uptake of dye into viable cells. Inserts
were washed twice in pre-warmed phosphate buffered
saline (Fisher Scientific UK Ltd, Loughborough, UK) to
remove any residual dye. After washing, cells were lysed
with 500 μl destain (50% ethanol, 49% distilled H2O, 1%
glacial acetic acid). Aliquots of 100 μl elutate were read
on a Multiskan Ascent Microplate Reader (Thermo Lab-
systems, Waltham, MA, USA) at a wavelength of 540
nm with a reference filter of 630 nm. Neutral Red
blanks were also included to remove background levels
of dye absorbed by the inserts. Viability of exposed cells
was calculated as a percentage of air controls.
Statistics
Data were reported as a mean ± standard deviation. For
syringe validation, a two-way ANOVA was used to com-
pare the syringe outputs at the two dilutions tested,
Dunnet’s test was used to compare results to target and
look at bias, and a Total Gage R&R test was used to
assess repeatability and reproducibility of all syringes at
both dilutions, data set n = 15 for both dilutions. For
transfer efficiency data, a General Linear Model (with
Tukey’s test) was used to test for differences in sample
point and tubing type, data set n = 3. A one-way
ANOVA was used to assess the differences in cell viabi-
lity measured during the exposure chamber dosimetry
study, data set n = 20. Statistical analysis for the above
investigations was conducted using MINITAB
® v.15.1.30
statistical software. All residual plots for all graphs were
checked to ensure the quality of the data obtained. A p-
value < 0.05 was considered statistically significant.
Deposition analysis using fluorescence was conducted
on GraphPad Prism
® v.5.02, data set was at least n = 4
for all dilutions tested and reported as a mean ± stan-
dard error of mean.
Conclusion
In conclusion, we present a reliable and repeatable
whole smoke exposure system consisting of a Borgwaldt
RM20S smoking machine and BAT’s exposure chamber.
We are confident this system can be used to expose in
vitro ALI cultures to eight independent and simulta-
neous doses of whole smoke knowing that smoke deliv-
ery, dilution precision, and chamber dose are
reproducible and expected. This study further supports
our previous study comparing syringe validation using
CH4 measurements in two different laboratories; one
being in the UK, the other in Canada [18].
This system will enable us to investigate the effects of
physiologically relevant whole cigarette smoke doses on
endpoints known to be relevant to major smoking
related disease, namely cancer and chronic obstructive
lung disease (chronic bronchitis and emphysema).
Furthermore, these results can be used to support and
enable quantification and alignment of whole smoke
doses with human dosimetry data; recent studies within
Group Research and Development (GR&D) BAT have
modelled and quantified regional tissue deposition of
smoke within the different compartments of the respira-
tory tract [29].
We propose to further use this exposure system for
the evaluation of future tobacco products designed to
reduce the harmful effects of smoke and to investigate
individual components of cigarette smoke. Furthermore,
this system could be a useful alternative in vitro method
for evaluating the effects of other aerosols and gaseous
mixtures such as air pollutants, inhaled pharmaceuticals
and cosmetics, and to examine occupational exposure
scenarios.
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